Tenet Healthcare (NYSE:THC) Stock Crosses Above 50-Day Moving Average – Here’s What Happened

Shares of Tenet Healthcare Corporation (NYSE:THC) crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $264.84 and traded as high as $271.61. Tenet Healthcare shares last traded at $267.7470, with a volume of 1,090,294 shares trading hands.

Tenet Healthcare News Summary

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported third-quarter earnings of $6.64 per share, well above the $4.68 consensus estimate, while revenue rose 6.5% year over year to $6.28 billion versus expectations of $5.49 billion. Strong hospital performance and cost discipline drove the earnings beat. Tenet Healthcare surpasses Q3 earnings and revenue estimates
• Positive Sentiment: Management raised its 2026 financial outlook and forecast adjusted EBITDA of $5.05 billion to $5.20 billion. Conifer transition-related items are expected to contribute to results, while improving hospital margins and higher-acuity services are strengthening the business outlook. Tenet forecasts 2026 adjusted EBITDA
• Positive Sentiment: Deutsche Bank raised its price target to $320 from $260 and maintained a Buy rating, signaling increased confidence in Tenet’s earnings momentum and valuation potential. Deutsche Bank raises Tenet price target
• Neutral Sentiment: Guggenheim modestly reduced its price target to $306 from $307 but retained a Buy rating, leaving its fundamental view constructive. Guggenheim Tenet Healthcare rating
• Negative Sentiment: Investors continue to face risks from payer pressure, uninsured patients and surgery-related headwinds. Commentary also noted that the headline earnings beat included transition-related benefits, which could make the results less representative of recurring performance. Tenet high-acuity strategy and third-quarter performance

Analysts Set New Price Targets

Several brokerages recently weighed in on THC. Morgan Stanley boosted their price objective on shares of Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. Royal Bank Of Canada raised their target price on Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Guggenheim cut their target price on Tenet Healthcare from $307.00 to $306.00 and set a “buy” rating on the stock in a report on Friday. Mizuho set a $290.00 price target on Tenet Healthcare in a research note on Monday, August 10th. Finally, Truist Financial raised their price target on shares of Tenet Healthcare from $270.00 to $290.00 and gave the stock a “buy” rating in a report on Tuesday, July 28th. Eighteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $280.16.

Tenet Healthcare Stock Performance

The company has a current ratio of 1.58, a quick ratio of 1.35 and a debt-to-equity ratio of 1.76. The company has a 50-day moving average price of $264.85 and a two-hundred day moving average price of $220.34. The stock has a market capitalization of $22.00 billion, a P/E ratio of 7.92, a price-to-earnings-growth ratio of 1.03 and a beta of 1.20.

Tenet Healthcare (NYSE:THC) last released its earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, topping the consensus estimate of $4.68 by $1.96. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The business had revenue of $6.28 billion during the quarter, compared to analysts’ expectations of $5.49 billion. During the same quarter last year, the firm posted $3.70 earnings per share. The firm’s revenue was up 6.5% on a year-over-year basis. On average, equities analysts forecast that Tenet Healthcare Corporation will post 20.90 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Nadja West sold 1,152 shares of the business’s stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $258.80, for a total transaction of $298,137.60. Following the transaction, the director owned 23,653 shares in the company, valued at $6,121,396.40. The trade was a 4.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard Mark sold 10,000 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $263.42, for a total transaction of $2,634,200.00. Following the transaction, the director directly owned 25,121 shares in the company, valued at approximately $6,617,373.82. This represents a 28.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 106,484 shares of company stock worth $28,898,063 over the last ninety days. 0.97% of the stock is owned by company insiders.

Institutional Trading of Tenet Healthcare

Several large investors have recently made changes to their positions in THC. Manning & Napier Advisors LLC bought a new position in Tenet Healthcare during the second quarter valued at about $168,761,000. Bank of New York Mellon Corp purchased a new stake in Tenet Healthcare during the second quarter worth about $106,342,000. Hsbc Holdings PLC raised its position in Tenet Healthcare by 3,478.7% in the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock worth $53,269,000 after acquiring an additional 258,956 shares during the period. Arrowstreet Capital Limited Partnership raised its position in Tenet Healthcare by 57.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock worth $126,757,000 after acquiring an additional 244,901 shares during the period. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its stake in Tenet Healthcare by 535.9% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 127,677 shares of the company’s stock valued at $24,094,000 after acquiring an additional 107,600 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Tenet Healthcare Company Profile

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.